COSM CEO Grigorios Siokas acquires 56,080 shares via debt swap

Rhea-AI Filing Summary

Cosmos Health Inc. (COSM) CEO, director and 10% owner Grigorios Siokas reported acquiring common stock through a debt-for-equity exchange. On 11/21/2025, he acquired 56,080 shares of common stock at $0.6776 per share, identified as Exchange Shares under a Debt Exchange Agreement between him and the company. The price reflects the fair market value of the stock on that date and was used to exchange $38,000 of debt the company owed to him. Following this transaction, he beneficially owned 6,327,893 shares of Cosmos Health common stock, held directly.

Insider Trade Summary

Net Buyer: 56,080 shares

Net Buy 1 txn

Insider Siokas Grigorios

Role Chief Executive Officer

Bought 56,080 shs ($38K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $.001	56,080	$0.6776	$38K

Holdings After Transaction: Common Stock, par value $.001 — 6,327,893 shares (Direct)

Footnotes (1)

1. F1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.6776 per share, the fair market value of the Common Stock on November 21, 2025, in exchange for a total amount of $38,000 in debt the Company owed to Mr. Siokas.

FAQ

What insider transaction did Cosmos Health (COSM) report in this Form 4?

The filing reports that CEO, director and 10% owner Grigorios Siokas acquired 56,080 shares of Cosmos Health common stock on 11/21/2025 through a debt-for-equity exchange.

At what price were the new Cosmos Health (COSM) shares acquired by the CEO?

Grigorios Siokas acquired the 56,080 shares at a price of $0.6776 per share, which the document states was the fair market value of the common stock on November 21, 2025.

How much company debt was exchanged for Cosmos Health (COSM) shares?

The transaction exchanged $38,000 of debt that Cosmos Health owed to Grigorios Siokas for common stock at the stated exchange rate of $0.6776 per share.

How many Cosmos Health (COSM) shares does the reporting person own after the transaction?

After the reported transaction, Grigorios Siokas beneficially owned 6,327,893 shares of Cosmos Health common stock, held in direct ownership.

What is the relationship of Grigorios Siokas to Cosmos Health (COSM)?

Grigorios Siokas is identified as a Director, Chief Executive Officer, and a 10% Owner of Cosmos Health Inc.

Was this Cosmos Health (COSM) Form 4 filed for one reporting person or multiple?

The Form 4 indicates it was filed by one reporting person, namely Grigorios Siokas.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/24/2025 - 02:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last) (First) (Middle)

5 AG. GEORGIOU STR

PILEA

(Street)

THESSALONIKI J3 TK57001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	11/21/2025	11/21/2025	P(1)		56,080	A	$0.6776	6,327,893	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.6776 per share, the fair market value of the Common Stock on November 21, 2025, in exchange for a total amount of $38,000 in debt the Company owed to Mr. Siokas.

Remarks:

	/s/ Grigorios Siokas	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.